Open Heart

MARCH 29, 2024

Coronary artery disease (CAD) is frequently found in this patient group and optimal management in these patients remains uncertain. Subsidiary outcomes included patient angina and breathlessness scores. After multivariate analysis, the presence of CAD had no effect on the primary outcome (HR 0.98, CI 0.68

Coronary Artery Disease 52

Coronary Artery Disease Aortic valve Aortic Outcomes 52

The American Journal of Cardiology

JANUARY 22, 2025

Publication date: Available online 20 January 2025 Source: The American Journal of Cardiology Author(s): Robert C. Stoler, Minseob Jeong, Talha Akram, Alec Monhollen, David Fernandez Vazquez, Mufaddal Mamawala, Trenton A. Witt, Blake Bruneman, Sarah Weideman, Kennedy S. Adelman, Shalini Sharma, Yumna Furqan, Zachary P.

Coronary Artery Disease 40

Coronary Artery Disease Outcomes 40

American College of Cardiology

MARCH 5, 2024

Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs. In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M.

Coronary Artery Disease 50

Coronary Artery Disease Outcomes Article 50

The British Journal of Cardiology

APRIL 2, 2025

HBOT is a promising treatment modality for coronary artery disease (CAD), where outcomes are frequently poor despite early revascularisation. The primary outcomes were left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF).

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Article 40

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release.

Coronary Artery Disease 64

Coronary Artery Disease Biomarkers Outcomes 64

European Journal of Heart Failure

MARCH 10, 2025

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Abstract Aims Clonal haematopoiesis (CH) is recognized as a significant risk factor for various non-haematologic conditions, including cardiovascular diseases. Clonal haematopoiesis and heart failure: a meta-analysis.

Heart Failure 40

Heart Failure Outcomes Coronary Artery Disease Risk Factors 40

Medical Xpress - Cardiology

APRIL 1, 2025

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.

Stents 74

Stents Stent Coronary Artery Disease Outcomes 74

Science Daily - Heart Disease

APRIL 15, 2025

A new study could lead to more widespread use of imaging technique to improve survival and prevent complications.

Coronary Artery Disease 62

Coronary Artery Disease Stents Stent Outcomes 62

Frontiers in Cardiovascular Medicine

APRIL 1, 2025

IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients. The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Biomarkers 52

Biomarkers Coronary Artery Disease Article Myocardial Infarction 52

Open Heart

JANUARY 6, 2022

Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. We aimed to perform a systematic review and meta-analysis to study the effects of colchicine in patients with symptomatic coronary artery disease (CAD) who have undergone PCI.

Coronary Artery Disease 52

Coronary Artery Disease Thrombosis Stents Stent 52

CardiacWire

APRIL 9, 2025

Evaluating the ACO incentives , researchers compared care quality data from the ACCs NCDR PINNACLE Registry before and 6-12 months after MSSP participation at 83 ACO outpatient cardiology practices versus 332 non-ACO practices and found MSSP ACO participation made no difference in coronary artery disease, HF, AFib, or hypertension outcomes.

Medicare 59

Medicare Outpatient Coronary Artery Disease AFIB 59

DAIC

MARCH 27, 2025

In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. 2023 Oct, 82 (16) 15981610.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

Open Heart

JANUARY 21, 2022

Deficits in health literacy are common in patients with coronary artery disease (CAD), and this is associated with increased morbidity and mortality. Five studies targeted interaction between patients and the health system; four of these reported improved outcomes, including through use of teach-back.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes 52

Circulation

APRIL 4, 2025

BACKGROUND:Shared genetic and lifestyle risk factors may underlie the development of both coronary artery disease (CAD) and dementia. Primary outcomes were incident all-cause, Alzheimers, and vascular dementia diagnoses obtained from electronic health records. Circulation, Ahead of Print. year follow-up.

Coronary Artery Disease 51

Coronary Artery Disease Dementia Risk Factors Outcomes 51

Heart BMJ

FEBRUARY 23, 2024

Coronary physiology assessment, including epicardial and microvascular investigations, is a fundamental tool in the contemporary management of patients with coronary artery disease. Coronary revascularisation guided by functional evaluation has demonstrated superiority over angiography-only-guided treatment.

Coronary Artery Disease 53

Coronary Artery Disease Physiology Coronary Artery Bypass Graft Quality of Life 53

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Coronary Artery Disease 40

Coronary Artery Disease Aortic valve Aortic Stenosis 40

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 64

DAIC

JUNE 11, 2024

A rare variant association study using exome sequencing data was performed on a machine learning-based marker for coronary artery disease (CAD). Our findings help us understand how these 17 genes are involved in coronary artery disease. Credit: Ron Do, PhD, and Ben Omega Petrazzini, BS, at Icahn Mount Sinai.

Heart Disease 105

Heart Disease Coronary Artery Disease Research Laboratory 105

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.

Coronary Artery Bypass Graft 59

Coronary Artery Bypass Graft Coronary Artery Disease Heart Failure Myocardial Infarction 59

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

BackgroundCoronary artery disease is a global health concern that necessitates treatments, such as percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Recent advancements in biodegradable polymer-coated DES have improved long-term outcomes by reducing neointimal hyperplasia.

Coronary Artery Disease 52

Coronary Artery Disease Stents Stent Outcomes 52

Journal of Cardiothoracic Surgery

JUNE 30, 2024

In patients with unprotected left main coronary artery disease (ULMCAD), this study compared the long-term prognosis of drug-eluting stent insertion guided by intravascular ultrasonography (IVUS) vs. angiography.

Coronary Artery Disease 40

Coronary Artery Disease Stents Stent Outcomes 40

American College of Cardiology

APRIL 26, 2024

Since limb events are major drivers of morbidity in diabetic patients with peripheral (PAD) and coronary artery disease (CAD), does the addition of ticagrelor to background therapy of aspirin improve limb events?

Diabetes 65

Diabetes Coronary Artery Disease Outcomes Article 65

Cardiometabolic Health Congress

JANUARY 16, 2025

Precision Medicine: Personalizing Prevention for Better Outcomes Precision medicine provides tools to customize prevention and treatment plans based on individual risk factors. Key strategies include: Polygenic Risk Scores: Identifying Risk Early PRS helps identify young adults at high lifetime risk for coronary artery disease (CAD).

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

Circulation

JANUARY 12, 2025

Circulation, Volume 151, Issue 2 , Page 193-195, January 14, 2025.

Coronary Artery Disease 49

Coronary Artery Disease Outcomes Circulation 49

Cardiovascular Diabetology

MAY 31, 2024

Coronary three-vessel disease (CTVD) accounts for one-third of the overall incidence of coronary artery disease, with heightened mortality rates compared to single-vessel lesions, including common trunk lesion.

Coronary Artery Disease 64

Coronary Artery Disease Outcomes Research 64

Cardiovascular Diabetology

JANUARY 5, 2024

The role of triglyceride-glucose (TyG) index, an insulin resistance indicator, in glycemic management for diabetic patients with coronary artery disease (CAD) was still unknown. Therefore, we aimed to explore.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Outcomes Research 40

Circulation

NOVEMBER 11, 2024

However, the long-term outcomes in patient with an intermediate stenosis received FFR have not yet been investigated comprehensively.Methods:We retrospective included 558 patients underwent both coronary artery angiography (CAG) and FFR. Circulation, Volume 150, Issue Suppl_1 , Page A4144277-A4144277, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Risk Factors Outcomes 40

Journal of the American Heart Association

JANUARY 19, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundCurrent guidelines recommend revascularization in patients with ischemic cardiomyopathy (ICM). CABG and PCI had comparable 30‐day risk‐adjusted mortality risks.

Coronary Artery Disease 40

Coronary Artery Disease Coronary Artery Bypass Graft Cardiomyopathy Stenosis 40

Open Heart

FEBRUARY 17, 2025

Background Percutaneous coronary intervention (PCI) is a well-established treatment for coronary artery disease, one of the most significant causes of morbidity and mortality worldwide.

Coronary Artery Disease 52

Coronary Artery Disease Ultrasound Hospital Outcomes 52

MIBHS

JANUARY 15, 2025

Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Poor healing can compromise the outcomes of bloodless surgeries, which rely on minimal incisions and precise techniques.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Blood Clot Blood Pressure Plaque 52

Coronary Artery Disease Journal

SEPTEMBER 24, 2024

Introduction Despite advancements in coronary artery disease (CAD) management, major adverse cardiovascular events persist. Primary outcomes included myocardial infarction, stroke, major bleeding events, and all-cause mortality. Vitamin K antagonists and direct oral anticoagulants present bleeding risks.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Stroke Strokes 40

DAIC

JANUARY 3, 2024

With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes. 3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

Cardiovascular Diabetology

JANUARY 21, 2024

The triglyceride-glucose (TyG) index is regarded as a dependable alternative for assessing insulin resistance (IR), given its simplicity, cost-effectiveness, and strong correlation with IR. The relationship be.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes Research 52

Circulation: Cardiovascular Interventions

APRIL 2, 2025

Circulation: Cardiovascular Interventions, Ahead of Print.

Coronary Artery Disease 40

Coronary Artery Disease Angioplasty Cardiovascular Interventions Circulation 40

American College of Cardiology

JULY 10, 2024

What is the outcome of contemporary revascularization strategies in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease (CAD)?

Coronary Artery Disease 55

Coronary Artery Disease Myocardial Infarction Outcomes Article 55

Cardiovascular Diabetology

FEBRUARY 2, 2024

The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of drug-coated balloons.

Coronary Artery Disease 52

Coronary Artery Disease Diabetes Outcomes Research 52

Nature Reviews - Cardiology

MAY 6, 2024

In this Perspective article, the authors propose that a similar illusion of revascularization exists for contemporary percutaneous revascularization in patients with coronary artery disease and ischaemia, and identify how outcomes might be improved.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Article Outcomes 64